Got a text today asking if I was interested in participating in a clinical trial for knee osteoarthritis.
It is early days - Phase 1A. The company is Cytonics and the drug CYT-108.
I've started researching a little and I'm reading some familiar themes.... 'Holy grail'....... 'may be the first and only disease-modifying pharmaceutical for OA'....... 'aim to partner with a mid-sized pharmaceutical company' ...... sound familiar?
They make interesting claims like:
In our preclinical studies, CYT-108 showcased promising results that emphasize its potential efficacy and safety. CYT-108 demonstrated up to 60% reduction in cartilage degradation and joint membrane inflammation compared to controls, and it was well-tolerated by the study subjects.
It's intraarticular. Haven't learnt much more yet.
If anyone knows much more about it, would love to hear.
There are a number of links but this one I found particularly interesting.
Mozz, I've got a feeling you've mentioned this one before????
Got a text today asking if I was interested in participating in...
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $103.1M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.0¢ | 29.5¢ | $34.55K | 115.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 40478 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 22/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |